Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
Price Target
Average
68.70%
Revenue Forecast
Estimate
11.79%
EBIT
Estimate
22.05%
Net Income
Estimate
21.45%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Regeneron Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for REGN of $1.15 K, with forecasts ranging from
a
low of
$805 to a high of $1.3 K.
REGN Lowest Price Target
Wall Street Target
805 USD
18.11%
REGN Average Price Target
Wall Street Target
1.15 K USD
68.70%
REGN Highest Price Target
Wall Street Target
1.3 K USD
90.73%
REVENUE FORECAST
Revenue Forecast Chart REGN
EBIT FORECAST
EBIT Forecast Chart REGN
NET INCOME FORECAST
Net Income Chart REGN